GLPwatch
Papers (12034)
Page 196 of 201, ranked by citation count.
- Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes.
- [The renal protective effect and mechanism of liraglutide in diabetic mice induced by high-fat diet].
- Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database.
- MAFLD/MASLD: Past, Present, and Future.
- [Pharmacotherapy for obesity].
- Effects of glucagon-like peptide-1 analogues on hard binary outcomes for patients at increased risk of cardiovascular events: a protocol for a systematic review with network meta-analysis and Trial Sequential Analysis.
- Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.
- Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity.
- The ESSENCE of hope: what semaglutide's Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis.
- Remission of erythromelalgia after semaglutide initiation: A case report.
- Development of zein-based nanoparticles for oral co-delivery of insulin and liraglutide and preliminary in vivo evaluation in Danio rerio.
- Semaglutide-Induced Ischemic Colitis in A Middle-Aged Female Without Vascular Risk Factors.
- Beyond weight loss: predictors of treatment satisfaction and patient-reported outcomes in incretin-based therapies. A cross-sectional study.
- GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns.
- [Impact of Elon Musk's statements on the use of semaglutide in the Lazio Region: a time series analysis study.]
- Adult Annular Pancreas Presenting With Gastric Outlet Obstruction Following Semaglutide Initiation: A Case Report.
- Semaglutide, Obesity-Related Heart Failure, and Type 2 Diabetes.
- Efficacy and safety of oral semaglutide as add-on therapy in poorly controlled type 2 diabetes on background SGLT2 inhibitors: a real-world, multi-center, retrospective, observational study (RYS2).
- [Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)].
- Atypical Anorexia Nervosa Developed in a Patient with Severe Obesity and Type 2 Diabetes Following Sleeve Gastrectomy and Postoperative Treatment with Semaglutide and Tirzepatide.
- In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wk.
- SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review.
- Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data.
- Effect of GLP-1 receptor agonists on idiopathic intracranial hypertension: A systematic review.
- Liraglutide Potently Protects Against Streptozotocin-Induced Islet Injury Associated with Inhibition of HMGB1 Release.
- GIPR:GCGR co-agonism restores normal weight in obese rodents.
- Six-month effects of liraglutide and dapagliflozin on lipid profile, cardiovascular risk, and NT-proBNP levels in patients with metabolic dysfunction-associated steatotic liver disease.
- ARPA-H bets big to foster drugs that thwart aging.
- Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists: A systematic review.
- Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectives.
- [Effects of glucagon-like peptide-1 on appetite and body weight: preclinical and clinical data].
- Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2).
- Cagrilintide-Semaglutide in Adults with Overweight or Obesity. Reply.
- Cagrilintide-Semaglutide in Adults with Overweight or Obesity.
- GLP-1 Receptor Agonists and Fertility: What Is Known So Far?
- Obesity Week 2016 Annual Meeting.
- The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.
- Web Exclusive. Annals On Call - Dulaglutide, Semaglutide, and Tirzepatide: How Do Gastrointestinal Adverse Effects Compare?
- Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis.
- Drugs and devices for weight management.
- Efficacy of Tirzepatide, Retatrutide, and Semaglutide for Weight Loss in Obese Individuals Without Diabetes.
- The impact of semaglutide on peri-operative cardiovascular outcomes in diabetes.
- GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety.
- [GLP-1 receptor agonists in hypertension - a new approach for difficult-to-treat blood pressure?]
- The unseen risk of Ozempic: NAION and vision damage.
- Benchmarking the medication efficiency and technological progress of diabetes drugs.
- A Case Report of Bezoar-Induced Small Bowel Obstruction: A Potential Surgical Complication of Semaglutide.
- Semaglutide-induced transient intestinal ischemia: A case report.
- Beyond weight loss: Effect of GLP-1 receptor agonist therapy on the urological health.
- Acute Systemic Complications Following High-Dose Semaglutide Reinitiation in an Elderly Patient.
- Efficacy and safety of pemvidutide in metabolic dysfunction-associated steatohepatitis: a GRADE-assessed meta-analysis of randomized controlled trials.
- Sustained Glycaemic Control and Preserved Beta-Cell Function in Newly Diagnosed Type 1 Diabetes Treated With Semaglutide.
- Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in Human Sinoatrial Node Cells.
- A retrospective audit of weight loss and health outcomes following bariatric surgery at a tertiary public hospital.
- Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
- Algorithm-Based Common Microcirculatory Framework for Monitoring and Visualizing the Integrated Pancreatic Microcirculation in Type 2 Diabetes Mellitus Mice.
- Simultaneous bilateral NAION following initiation of high-dose semaglutide: a case report.
- Corrigendum to Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
- A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
- Effect of Liraglutide combined with Jinlida granules on glycolipid metabolism and islet function of type 2 diabetes mellitus.